139 related articles for article (PubMed ID: 16680017)
1. Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2006 May; 25(5):515-21. PubMed ID: 16680017
[TBL] [Abstract][Full Text] [Related]
2. 5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Sautebin L; Caputi AP; Cuzzocrea S
Shock; 2006 Apr; 25(4):377-83. PubMed ID: 16670640
[TBL] [Abstract][Full Text] [Related]
3. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2007 Aug; 28(2):192-201. PubMed ID: 17515853
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
5. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Cuzzocrea S
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):45-57. PubMed ID: 12839336
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies.
Fries W; Muja C; Crisafulli C; Cuzzocrea S; Mazzon E
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G938-47. PubMed ID: 18258792
[TBL] [Abstract][Full Text] [Related]
7. Experimental colitis increases small intestine permeability in the rat.
Fries W; Mazzon E; Squarzoni S; Martin A; Martines D; Micali A; Sturniolo GC; Citi S; Longo G
Lab Invest; 1999 Jan; 79(1):49-57. PubMed ID: 9952110
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
9. Role of peroxisome proliferator-activated receptor-alpha in ileum tight junction alteration in mouse model of restraint stress.
Mazzon E; Crisafulli C; Galuppo M; Cuzzocrea S
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G488-505. PubMed ID: 19556362
[TBL] [Abstract][Full Text] [Related]
10. Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress.
Mazzon E; Cuzzocrea S
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1268-80. PubMed ID: 18308862
[TBL] [Abstract][Full Text] [Related]
11. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Puzzolo D; Caputi AP; Cuzzocrea S
Mol Med; 2002 Jul; 8(7):353-66. PubMed ID: 12393933
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
13. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
[TBL] [Abstract][Full Text] [Related]
15. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis.
Mazzon E; Esposito E; Crisafulli C; Riccardi L; Muià C; Di Bella P; Meli R; Cuzzocrea S
J Pineal Res; 2006 Nov; 41(4):363-73. PubMed ID: 17014694
[TBL] [Abstract][Full Text] [Related]
16. Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability.
Cuzzocrea S; Mazzon E; De Sarro A; Caputi AP
Mol Med; 2000 Sep; 6(9):766-78. PubMed ID: 11071271
[TBL] [Abstract][Full Text] [Related]
17. Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
Prakash O; Medhi B; Saikia UN; Pandhi P
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):9-16. PubMed ID: 18598295
[TBL] [Abstract][Full Text] [Related]
18. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis.
Kawaguchi T; Sakisaka S; Mitsuyama K; Harada M; Koga H; Taniguchi E; Sasatomi K; Kimura R; Ueno T; Sawada N; Mori M; Sata M
Hepatology; 2000 Jun; 31(6):1285-95. PubMed ID: 10827154
[TBL] [Abstract][Full Text] [Related]
19. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
Ursino MG; Vasina V; De Ponti F
Eur J Pharmacol; 2009 Jan; 603(1-3):133-7. PubMed ID: 19103194
[TBL] [Abstract][Full Text] [Related]
20. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
